Improved reduction of cardiovascular risk by bedtime ingestion of ARB and ACEI medication class therapies

Ramón C Hermida¹, Juan J Crespo^{1

2}, Manuel Domínguez-Sardiña²

Affiliations

¹ Bioengineering & Chronobiology Laboratories, Atlantic Research Center for Informatio n and Communication Technologies (AtlantTIC), University of Vigo, Campus Universitario, Vigo 36310, Spain.
² Estructura de Xestión Integrada de Vigo, Servicio Galego de Saúde (SERGAS), Vigo 36214, Spain.

Comment

Ramón C Hermida et al. Eur Heart J. 2020.

. 2020 Apr 21;41(16):1602-1603.

doi: 10.1093/eurheartj/ehaa214.

Ramón C Hermida¹, Juan J Crespo^{1

2}, Manuel Domínguez-Sardiña²

¹ Bioengineering & Chronobiology Laboratories, Atlantic Research Center for Informatio n and Communication Technologies (AtlantTIC), University of Vigo, Campus Universitario, Vigo 36310, Spain.
² Estructura de Xestión Integrada de Vigo, Servicio Galego de Saúde (SERGAS), Vigo 36214, Spain.

No abstract available

Comment on

Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.
Hermida RC, Crespo JJ, Domínguez-Sardiña M, Otero A, Moyá A, Ríos MT, Sineiro E, Castiñeira MC, Callejas PA, Pousa L, Salgado JL, Durán C, Sánchez JJ, Fernández JR, Mojón A, Ayala DE; Hygia Project Investigators. Hermida RC, et al. Eur Heart J. 2020 Dec 21;41(48):4565-4576. doi: 10.1093/eurheartj/ehz754. Eur Heart J. 2020. PMID: 31641769 Clinical Trial.
Chrono-pharmacological effects of antihypertensive drugs.
Şen S, Kaşkal M, Üresin Y. Şen S, et al. Eur Heart J. 2020 Apr 21;41(16):1601. doi: 10.1093/eurheartj/ehaa213. Eur Heart J. 2020. PMID: 32298408 No abstract available.